Bimakalim
Alternative Names: EMD 52692Latest Information Update: 21 May 2002
At a glance
- Originator Merck KGaA
- Class Antihypertensives; Benzopyrans; Dihydropyridines; Ischaemic heart disorder therapies; Small molecules; Vasodilators
- Mechanism of Action KATP channel stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Angina pectoris; Arrhythmias; Asthma; Heart failure; Hypertension
Most Recent Events
- 20 Sep 2000 No-Development-Reported for Arrhythmias in Italy (Unknown route)
- 20 Sep 2000 No-Development-Reported for Asthma in Germany (Unknown route)
- 20 Sep 2000 No-Development-Reported for Asthma in Italy (Unknown route)